FDA moves to fast-track review of three psychedelic drug studies
- Posted on April 24, 2026
- By The Hill
- 0 Views
- 1 min read
FDA moves to fast-track review of three psychedelic drug studies
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression and post-traumatic stress disorder (PTSD), the lates…
